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Background: Little is known about the relationships of circulating levels of biomarkers of cartilage degradation
with biomechanical outcomes relevant to knee osteoarthritis (OA) or biomarker changes following
non-pharmacological interventions. The objectives of this exploratory, pilot study were to: 1) examine
relationships between biomarkers of articular cartilage degradation and synthesis with measures of knee joint
load during walking, and 2) examine changes in these biomarkers following 10 weeks of strengthening exercises.
Methods: Seventeen (8 male, 9 female; 66.1 +/- 11.3 years of age) individuals with radiographically-confirmed
medial tibiofemoral OA participated. All participants underwent a baseline testing session where serum and urine
samples were collected, followed by a three-dimensional motion analysis. Motion analysis was used to calculate the
external knee adduction moment (KAM) peak value and impulse. Following baseline testing, participants were
randomized to either 10 weeks of: 1) physiotherapist-supervised lower limb muscle strengthening exercises, or
2) no exercises (control). Identical follow-up testing was conducted 11 weeks after baseline. Biomarkers included:
urinary C-telopeptide of type II collagen (uCTX-II) and type II collagen cleavage neoepitope (uC2C), serum cartilage
oligomeric matrix protein (sCOMP), serum hyaluronic acid (sHA) and serum C-propeptide of type II procollagen
(sCPII). Linear regression analysis was used to examine relationships between measures of the KAM and biomarker
concentrations as baseline, as well as between-group differences following the intervention.
Results: KAM impulse predicted significant variation in uCTX-II levels at baseline (p = 0.04), though not when
controlling for disease severity and walking speed (p = 0.33). KAM impulse explained significant variation in the ratio
uCTX-II;sCPII even when controlling for additional variables (p = 0.04). Following the intervention, changes in sCOMP
were significantly greater in the exercise group compared to controls (p = 0.04). On average those in the control
group experienced a slight increase in sCOMP and uCTX-II, while those in the exercise group experienced a
reduction. No other significant findings were observed.
Conclusions: This research provides initial evidence of a potential relationship between uCTX-II and knee joint load
measures in patients with medial tibiofemoral knee OA. However, this relationship became non-significant after
controlling for disease severity and walking speed, suggesting further research is necessary. It also appears that
sCOMP is amenable to change following a strengthening intervention, suggesting a potential beneficial role of
exercise on cartilage structure.
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Osteoarthritis (OA) is a common chronic health condition
resulting in significant personal and economic burdens. In
the absence of a cure, the main areas of research to-date
have centred on developing treatments that can improve
symptoms of pain and physical dysfunction as well as
improving methods to diagnose the disease and to monitor
progression. Most commonly affecting the knee, much of
the current literature in these two research areas has been
conducted in populations with knee OA.
Plain radiographs remain the most commonly used
clinical method of assessing joint structure for the purposes
of OA diagnosis and classification of severity. Magnetic
resonance imaging (MRI) has also been used to assess
changes in the morphology of the bone and cartilage to
supplement radiographical findings [1]. Though these
approaches are reliable and well-established clinically, their
use for the monitoring of changes in cartilage over time is
limited by the fact that these changes take place over long
periods of time and simply detail soft tissue damage that
has already occurred [2]. Indeed, a recent systematic review
showed greater responsiveness of radiographic joint space
width measurements in studies using follow-up periods of
greater than 2 years [3]. Given that significant changes in
symptoms and joint structure can occur over the course of
2 years, coupled with the fact that most non-surgical
and non-pharmacological interventions are conducted
over months instead of years, improved methods of
assessing changes in cartilage structure and outcomes
following shorter-terms treatments over shorter periods of
time are needed.
Joint tissue-related biomarkers in the blood and urine
have been used to further the understanding of the patho-
genesis of knee OA. Many biomarkers are produced during
the synthesis or degradation of articular cartilage and are
found in different concentrations based on the presence
and severity of knee OA [4,5]. For example, the biomarkers
C-propeptide of type II procollagen (CPII), hyaluronic acid
(HA), and cartilage oligomeric matrix protein (COMP) in
serum, as well as C-telopeptide of type II collagen (CTX-II)
and type II collagen cleavage neopeptide (C2C) in the urine
have all been shown to be elevated based on the presence
and severity of knee OA [6]. Importantly, given that their
concentrations reflect processes directly implicated in the
synthesis or degradation of articular cartilage, analysis of
biomarker concentrations may represent an effective
method of assessing cartilage structure over shorter periods
of time than conventional methods such as radiography or
MRI. However, much is still unknown about these bio-
markers, including factors involved in their production and
responses to non-pharmacological interventions.
Excessive joint loading is a recognized risk factor for
breakdown of articular cartilage based on early in vitro
studies [7]. These findings have been supported by later gaitanalysis studies showing a significantly higher rate of knee
OA progression over six years in people with high baseline
peak external knee adduction moment (KAM) values [8] –
a valid and reliable measure of medial compartment knee
joint load during walking [9-11] – as well as a relationship
between knee cartilage volume loss over twelve months
and the baseline KAM impulse [12] – the time integral of
the KAM during stance [13]. A link between joint load and
biomarker concentrations has also been reported. Piscoya
et al. [14] have shown increases in COMP production in
response to dynamic mechanical load in cartilage explants,
and acute bouts of moderately intense physical activity have
been shown to temporarily increase the concentration of
sCOMP in healthy individuals [15] as well as those with
knee OA [16,17]. However, the relationships between other
cartilage biomarkers and measures of everyday joint load-
ing, such as the KAM, are less well known. Further, the
effects of common non-pharmacological interventions on
biomarker concentrations are also not known.
Given the paucity of research on the relationships of
OA biomarkers with joint loading and changes following
exercise, the purpose of the present exploratory, pilot
study was to address these two knowledge gaps in a
sample of individuals with knee OA. Specifically, the
primary objective of this study was to determine the
relationships between different biomarker concentra-
tions and knee joint load, as measured by the KAM.
The secondary objective was to examine changes in




Community-based volunteers over the age of 50 years
were recruited through advertisements in local newspa-
pers. All had OA in at least one knee according to the
American College of Rheumatology classification criteria
[18] and reported average knee pain >3/10 on most days
of the previous month. All participants had varus align-
ment and OA predominantly in the medial tibiofemoral
compartment. Exclusion criteria included: history of
knee replacement surgery or high tibial osteotomy; any
knee surgery or corticosteroid injections within the pre-
vious 6 months; currently participating in, or intention
to begin structured lower limb strengthening exercises
within the next 3 months; inability to complete exercises
at home or attend 5 visits with the study physiotherapist;
and, BMI > 35 to reduce soft tissue artifact of marker
movement during quantitative gait analysis. For this
pilot study, our aim was to recruit between 15 and 20
individuals. This study was approved by the Clinical
Research Ethics Board of the University of British
Columbia and all participants provided written informed
consent prior to enrollment.
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A pilot 10-week, randomized, assessor-blinded, controlled
trial was conducted (Figure 1). Interested participants
underwent an initial phone screening based on the above-
mentioned inclusion and exclusion criteria. Next, standing




















































5 x Individual treatment sessions 
plus home exercises 4 x per week






















Figure 1 Study participant flowchart.radiographic severity using the Kellgren and Lawrence (KL)
classification system [19], and measured for lower limb
alignment using published regression equations for short-
film radiographs [20]. Those meeting all inclusion criteria
were invited to attend a baseline testing session in our
laboratory. In cases of bilateral symptoms and radiographicExcluded (n=31)
Too far to travel/ unable to 
attend (n=8)
Other pain/ pathology (n=7)
BMI >35 (n=5)
Knee pain <3/10 (n=5)







No longer interested (n=4)
Did not meet OA inclusion 
criteria (n=2)
Scheduled for surgery (n=1)
Presence of hip OA not 






Allocated to control group (n=8)
Continued with usual activities–no
exercise treatment
Lost to week 11 assessment (n=1)
- hospitalized due to fall (n=1)
Analyzed (n=7)
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determined to be the study limb. Upon completion of data
collection, participants were randomly allocated to
either the exercise or no exercise (control) group.
Randomization was conducted by an investigator not
involved with outcome assessment using sealed and
consecutively numbered opaque envelopes containing
the group allocation information according to a
computer-generated random number.
Interventions
Those randomized to the exercise group received a set
of 6 exercises designed to strengthen the hip abductors
(standing and side lying hip abduction), quadriceps
(standing lunges, mini-squats, seated knee extension),
and hamstrings (flexion to 90 degrees while maintaining
standing balance on the contralateral limb – with hand
support if required) muscle groups. When applicable,
additional resistance was provided using ankle cuff weights
to achieve sufficient exercise intensity for participants to
complete 3 sets of 10 repetitions for each exercise (defined
as the largest weight that the participant could successfully
and safely use to complete the 3 sets). Exercises were
performed a minimum of 4 days per week at home
for 10 weeks, and exercise performance and safe progres-
sion of resistance was monitored across five visits with the
study physiotherapist (MAH) at weeks 1, 2, 3, 5, and 8 of
the intervention. Adherence was quantified as the number
of home exercise days completed (maximum of 40 days) as
well as the number of physiotherapy visits (maximum of 5
visits), converted to a percentage.
Those in the control group did not receive any
additional intervention for the 10-week duration of
the study and were instructed to maintain their
usual clinical management for knee OA.
Outcome measures
Outcome assessment was conducted at baseline and at
follow-up (11 weeks) by an assessor blinded to group allo-
cation. Each assessment session included the collection of
blood and urine, three dimensional gait analysis, and
strength assessment. All outcome measurements were
completed within a 2-hour period at the same facility.
1) Biomarker assessments
Serum and urine samples were collected following a
30 minute rest period in which the participant
remained seated. All samples were processed and
immediately stored at –20°C, then transferred within
one week to a –80°C freezer until analysis. Analyses
were conducted at two sites by investigators with
previous biomarkers analysis experience [4]. Serum
concentrations of CPII (IBEX, Montreal, Canada)
were analyzed using an enzyme-linkedimmunosorbent assay (ELISA) designed to detect
the carboxy-propeptide that is released from type II
collagen following new procollagen synthesis. Serum
HA (Corgenix, Broomfield, USA) was analyzed by a
sandwich ELISA utilizing HA binding protein as the
capture molecule. Serum COMP was analyzed using
a sandwich ELISA that uses antibodies directed
against known antigenic determinants of human
COMP (AnaMar, Lund, Sweden). CTX-II (IDS,
Bolton, UK) in the urine was quantified using an
ELISA based on a sequence found exclusively in
human type II collagen. Urinary C2C was measured
using an ELISA (IBEX, Montreal, Canada) that
measures the carboxy-terminus of the primary type
II collagen cleavage generated by collagenases.
Urinary CTX-II and C2C were corrected for
creatinine excretion levels quantified by ELISA
(Quidel, San Diego, USA). Intra-assay coefficients of
variation were as follows: sCPII, 4.7%; sHA, 5.4%;
sCOMP 2.8%; uCTXII, 2.8%; uC2C, 3.5%. All
samples yielded measurable concentrations for all 5
biomarkers. All analyses were conducted in
duplicate and blinded to treatment status.
2) Knee joint loading during walking
Participants underwent three-dimensional gait
analysis while walking barefoot and at a self-selected
speed. Reflective markers were positioned over lower
limb anatomical landmarks during walking as well as
over the medial femoral epicondyles and medial
malleoli during an initial static standing trial used to
determine joint centre locations. Kinematic data
were collected using 8 high-speed digital video
cameras (Motion Analysis Corp., Santa Rosa, CA)
sampling at 120 Hz. Kinetic data were sampled at
1200 Hz using 2 floor-mounted force platforms
(Advanced Mechanical Technology Inc., Watertown,
MA) positioned in the middle of the walkway and
synchronized with the cameras. Net joint moments
were calculated using commercially available
software (Orthotrak, Motion Analysis Corp., Santa
Rosa, CA). The peak KAM (maximum value during
stance) was identified, and the KAM impulse
(positive area under the KAM-time curve) was
calculated, for each trial and averaged across a total
of 5 trials with clean force platform strikes by the
study limb.
3) Other measures
Isometric muscle strength was assessed using
dynamometry. Isometric knee extension and flexion
strength was measured using an isokinetic
dynamometer (Biodex, Shirley, NY) while the
participant was seated and the knee placed in 40
degrees of flexion. Isometric hip abduction strength
was measured using a handheld dynamometer
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lateral femoral epicondyle. For each muscle group,
participants performed three repetitions of maximal
voluntary isometric contractions for five seconds
each. The maximum force production across the
three trials was averaged and converted to a torque
by multiplying by the lever arm, then normalized to
body mass (Nm/kg). Participants randomized to the
exercise groups completed a weekly diary to record
adherence to the home exercise program.Statistical analysis
Biomarker data were log-transformed and used as
dependent variables in linear regression models with joint
load (either peak KAM or KAM impulse) used as the inde-
pendent variable to predict variance in each biomarker,
while controlling for age and sex [21], with additional
models also controlling for KL grade and walking speed.
Group membership (exercise or no exercise) was added in
regression models to predict change in log biomarker levels
while adjusting for age and sex, using intention-to-treat
principles. Finally, changes in KAM peak and impulse as
well as muscle strength were analyzed using repeated
measures analysis of variance for descriptive purposes as an
indication of the biomechanical and functional effects of
the intervention.
Results
Seventeen participants (8 males, 9 females; mean (SD)
age = 66.1 (11.3) years, BMI = 27.0 (4.5) kg/m2) were en-
rolled in the study. Ten participants had mild OA (KL 2),
five had moderate OA (KL 3), and two had severe OA (KL
4). Baseline demographic and clinical data were similar
between the two groups. Sixteen participants (five males
and four females from the exercise group and three males
and five females from the control group) returned for the
follow-up assessment a mean (SD) of 76.3 (5.3) days after
the baseline assessment. Blinding of group allocation to the
assessor was maintained for all participants. The time of
sample collection was consistent between baseline and
follow-up for each participant with the mean (SD) diffe-
rence being 20 (21) minutes (maximum= 65 minutes).
Most (13/17) participants provided samples and underwent
biomechanical testing in the morning prior to 11:00 am.
Attendance at the supervised physiotherapy sessions was
high in the exercise group with participants attending a
mean (SD) of 91% (14%) of the sessions. Home exercise
adherence rates were also high with a mean (SD) of 83%
(17%) of the exercise days completed.
Across all participants at baseline, and while adjusting for
age and sex, KAM impulse predicted significant variation
in uCTX-II levels (β = 1.19, 95% CI = 0.16, 2.21; p = 0.05) as
well as the uCTX-II:sCPII ratio (β = 1.50, 95% CI = 0.72,
2.28; p < 0.01). However, when KL grade and walking speedwere added to the regression models, the relationship with
uCTX-II became non-significant (β = 0.58, 95% CI = -0.53,
1.68, p = 0.33), while the significant relationship with
uCTX-II:sCPII remained (β = 1.11, 95% CI = 0.15, 2.07;
p = 0.04). In contrast, peak KAM was not able to explain
any significant amount of variation in any biomarker or
ratio when accounting for age and sex or when adding KL
grade and walking speed to the models (p > 0.34). No
other significant findings were found for either measure of
KAM in any biomarker regression model.
When comparing changes between groups following
the intervention (Table 1), significantly greater reductions
in sCOMP (β = 0.16, 95% CI = 0.02, 0.30; p = 0.04) as well
as slightly greater, non-significant reductions in uCTX-II
(β = 0.33, 95% CI = 0.04, 0.71; p = 0.11) were observed in
the exercise group compared to those in the control group.
No other significant between-group differences existed in
any single biomarker outcome or biomarker ratio. Finally,
no significant between-group differences were observed in
any gait or strength outcome (p > 0.11).
Discussion
This pilot study provides new information regarding the
characteristics of articular cartilage biomarkers relevant
to the study and treatment of knee OA. Specifically, this
study provides the first data detailing the relationship
between multiple OA biomarkers and a measure of
dynamic knee joint load – a potential mechanism of OA
biomarker production – as well as changes in biomarker
concentrations following exercise. Both study objectives
taken together, these data provide some support to further
explore the utility of uCTX-II and sCOMP as biomarkers
relevant to knee OA.
Previous animal studies have shown a direct relationship
between load magnitude and articular cartilage degradation
[22]. The data from the present study provide some evi-
dence that higher musculoskeletal loading can be associated
with increased circulating levels of uCTX-II, though a
causative relationship cannot be claimed based on the
current data. Furthermore, recent evidence suggests that
uCTX-II levels may arise from bone as well as cartilage
[23]; however, higher loading applied to the bone would
presumably increase uCTX-II levels under the same mech-
anism as uCTX-II derived from cartilage. Though the
KAM is a well-accepted and valid measure of medial
compartment joint load [10] with significant relationships
with many clinical outcomes specific to knee OA in the
medial compartment [8,24-29], it does not represent the
total load within the knee joint [30] nor does it account for
any potential changes in joint contact force that may result
from increased muscle activity [31]. Further, though a
significant relationship was observed between KAM
impulse and uCTX-II at baseline, this relationship became
non-significant when adjusting for disease severity and
Table 1 Mean (SD) values for KAM and strength outcomes as well as for log-transformed, unadjusted biomarker levels
and ratios of degradation to synthesis (sCPII) at baseline and follow-up for each group
Baseline data (n = 17) Follow-up data (n = 16) Between-group changes
Exercise No exercise Exercise No exercise Difference p-value
Gait outcomes
Peak KAM (%BW*ht) 3.75 (0.91) 3.38 (0.78) 3.70 (0.91) 3.21 (0.95) 0.04 (-0.64, 0.72) 0.91
KAM impulse (%BW*ht*sec) 1.13 (0.40) 1.32 (0.41) 1.01 (0.35) 1.24 (0.55) –0.05 (–0.23, 0.32) 0.72
Walking speed (m/s) 1.18 (0.23) 1.03 (0.17) 1.28 (0.18) 1.04 (0.16) 0.08 (–0.02, 0.18) 0.11
Strength outcomes
Knee extension torque (Nm/kg) 1.25 (0.34) 0.98 (0.25) 1.35 (0.39) 0.97 (0.23) 0.10 (–0.25, 0.06) 0.19
Knee flexion torque (Nm/kg) 1.06 (0.33) 0.82 (0.29) 1.12 (0.35) 0.70 (0.48) 0.18 (–0.41, 0.06) 0.12
Hip abduction torque (Nm/kg) 0.78 (0.19) 0.59 (0.26) 0.87 (0.28) 0.69 (0.13) –0.02 (–0.14, 0.18) 0.77
Urinary markers
uCTX-II (log ng/mmol creatinine) 5.40 (0.81) 5.97 (0.57) 5.32 (0.93) 6.25 (0.68) –0.33 (–0.71, 0.04) 0.11
uC2C (log μg/mmol creatinine) 2.45 (0.68) 2.46 (0.76) 2.57 (0.81) 2.71 (0.58) –0.10 (–0.35, 0.16) 0.73
Serum markers
sHA (log U/L) 3.47 (0.93) 3.80 (0.96) 3.26 (1.13) 4.21 (0.86) –0.79 (–1.67, 0.08) 0.10
sCOMP (log U/L) 2.20 (0.21) 2.26 (0.17) 2.11 (0.24) 2.36 (0.13) –0.16 (–0.30,–0.02) 0.04
sCPII (log U/L) 6.56 (0.19) 6.44 (0.53) 6.50 (0.36) 6.71 (0.40) –0.34 (–0.94, 0.24) 0.27
Ratios
uCTX-II:sCPII –1.16 (0.74) –0.46 (0.49) –1.18 (0.97) –0.46 (0.81) 0.01 (–0.63, 0.66) 0.97
uC2C:sCPII –4.11 (0.69) –3.98 (1.19) –3.93 (0.98) –4.01 (0.73) 0.22 (–0.59, 1.03) 0.61
sHA:sCPII –3.09 (0.99) –2.64 (0.87) –3.24 (1.37) –2.50 (0.77) –0.45 (–1.43, 0.53) 0.39
Group comparisons (exercise – no exercise) denote the difference in mean change (95% CIs). Between-group mean differences for gait and strength data are
unadjusted, while biomarker data for each log-transformed biomarker and ratio using linear regression modeling while adjusting for age and sex. Note that
negative log-transformed values indicate that the absolute ratio was less than 1.0, with greater negative values indicating a smaller ratio of the degradation
biomarker to the synthesis biomarker sCPII. Thus, improvements in the ratio of degradation to synthesis would be reflected in smaller negative values
at follow-up.
Hunt et al. BMC Musculoskeletal Disorders 2013, 14:115 Page 6 of 8
http://www.biomedcentral.com/1471-2474/14/115walking speed, and no relationship was found when exam-
ining the peak KAM value. Although dynamic knee joint
load may play a role in the production of biomarkers – in
particular, uCTX-II – it is not the only factor involved in
this process and evaluation of a single component of overall
joint load (KAM) does not necessarily represent the forces
experienced by the cartilage in their entirety. It is clear that
more research needs to be done to understand better the
relationship between knee joint biomechanics and OA
biomarkers.
The second objective of this study was to examine
changes in biomarker concentrations following an exercise
intervention. Results provide some evidence of a beneficial
role of exercise on joint integrity at the cartilage level. Spe-
cifically, those in the exercise group demonstrated reduced
mean sCOMP levels following the intervention compared
to those in the control group. Previous studies have shown
reductions in sCOMP following a single muscle strength-
ening session [32], though increases in sCOMP levels
immediately following moderate exercise have also been
reported [17]. Given that no significant between-groupdifferences in muscle strength or KAM were observed, it is
unlikely that the reductions in sCOMP were due to reduc-
tions in joint load. Indeed, baseline results from this study
did not provide evidence of a relationship between
dynamic joint load during walking and sCOMP levels. This
is in contrast to uCTX-II and may suggest that production
of uCTX-II and sCOMP occurs due to different mecha-
nisms. This hypothesis cannot be tested using the current
study design or data and requires further research.
Though the current results provide new information,
this study does have some limitations. First, the small
sample size in this pilot study may have reduced statistical
power and the ability to make more definitive conclusions.
Nevertheless, despite the small sample size, we did find
some statistically significant results. Also, the biomarker
concentrations measured in this study represent systemic
levels that could theoretically have arisen from any num-
ber of joints in the body. However, the normal turnover of
type II collagen in the body is relatively low, suggesting
that significant changes in systemic levels may be expected
to be due to pathological turnover from a single joint [33].
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skin movement artifact during walking, as is commonly
used in motion analysis studies measuring the KAM
[34-36] to maximize gait data accuracy. However, given
that many people with knee OA are overweight or obese,
the results of this study cannot necessarily be generalized
to the entire knee OA population, and our findings must
be viewed in light of this limitation.
Conclusions
This study provides initial evidence of a potential relation-
ship between loading in the knee joint during walking and
circulating levels of biomarkers associated with articular
cartilage degradation, specifically uCTX-II. A beneficial
effect of strengthening exercises on cartilage health as
evidenced by reduced levels of circulating sCOMP was also
concluded from the results, though the mechanism of this
finding is unknown. Further research with more subjects
and a longer intervention period would provide verification
of these findings and enhance our understanding of the
utility of biomarkers in the diagnosis of knee OA as well as
their potential as outcome measures following treatment.
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